Mix dantrolene as quickly as possible and hand to
anesthesia for rapid IV push.
DANTROLENE NURSE
Continue mixing dantrolene vials as anesthesia calls
for them.
Have pre-filled syringes ready to hand off.
Monitor anesthesia for additional vials needed.
Remind anesthesia to call out vials used to ensure
adequate supply.
Be prepared to mix additional vials as needed.
Stay focused on mixing dantrolene as quickly as
possible.
COOLING NURSE
Obtain ice
Post anesthesia care unit or , High Dependency unit is part of hospital for Post surgery/procedures recovery.Nursing, anesthesiologist, surgeons, hospital administration need to know about ideal conditions.
Malignant Hyperthermia - Essential Charactistics:
>An inherited disorder of skeletal muscle triggered in susceptibles (human or animal) in most instances by inhalation agents and/or succinylcholine, resulting in hypermetabolism, skeletal muscle damage, hyperthermia, and death if untreated.
>Underlying physiologic mechanism – abnormal handling of intracellular calcium levels.
Post anesthesia care unit or , High Dependency unit is part of hospital for Post surgery/procedures recovery.Nursing, anesthesiologist, surgeons, hospital administration need to know about ideal conditions.
Malignant Hyperthermia - Essential Charactistics:
>An inherited disorder of skeletal muscle triggered in susceptibles (human or animal) in most instances by inhalation agents and/or succinylcholine, resulting in hypermetabolism, skeletal muscle damage, hyperthermia, and death if untreated.
>Underlying physiologic mechanism – abnormal handling of intracellular calcium levels.
The number of patients with implantable devices continues to grow. There are important aspects and difficulties in the perioperative management of these patients.
The slides describes the medical emergencies which occurs in dentistry and their management in daily practice and awareness about the different medical emergencies in dentistry.
Malignant hyperthermia is a potentially fatal hyperdynamic response due to pharmacogenetic abnormalities. This ppt gives a brief description of pathology and pharmacotherapy of malignant hyperthermia.
Epilepsy
Epilepsy is a group is neurological disorder. An epileptic seizure is a paroxysm(sudden) of uncontrolled discharges of neurons causing an event that is discernible(visible) by the person experiencing the seizures or by the observer. The tendency to have recurrent attacks is known as epilepsy.
phenytoin,phenobarbital,sodium valporate ,carbamazepine,clonazepam and diazepam, lamotrigine,pregabalin,felbamate,zonisamide, ETHOSUXIMIDE, LEVETIRACETAM, OXACARBAZEPINE, PRIMIDONE
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxEduSkills OECD
Andreas Schleicher presents at the OECD webinar ‘Digital devices in schools: detrimental distraction or secret to success?’ on 27 May 2024. The presentation was based on findings from PISA 2022 results and the webinar helped launch the PISA in Focus ‘Managing screen time: How to protect and equip students against distraction’ https://www.oecd-ilibrary.org/education/managing-screen-time_7c225af4-en and the OECD Education Policy Perspective ‘Students, digital devices and success’ can be found here - https://oe.cd/il/5yV
Ethnobotany and Ethnopharmacology:
Ethnobotany in herbal drug evaluation,
Impact of Ethnobotany in traditional medicine,
New development in herbals,
Bio-prospecting tools for drug discovery,
Role of Ethnopharmacology in drug evaluation,
Reverse Pharmacology.
How to Split Bills in the Odoo 17 POS ModuleCeline George
Bills have a main role in point of sale procedure. It will help to track sales, handling payments and giving receipts to customers. Bill splitting also has an important role in POS. For example, If some friends come together for dinner and if they want to divide the bill then it is possible by POS bill splitting. This slide will show how to split bills in odoo 17 POS.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
2. WHAT IS MALIGNANT HYPERTHERMIA?
“Malignant Hyperthermia (MH) is a biochemical chain
reaction response triggered by commonly used general
anesthetics and the paralyzing agent succinylcholine,
within the skeletal muscles of susceptible individuals.”
- MHAUS.org
MH is a rare but deadly hypermetabolic event.
Complications include cardiac arrest, brain damage,
internal bleeding, organ system failure and death, due to
cardiovascular collapse.
3. PATHOPHYSIOLOGY OF
MALIGNANT HYPERTHERMIA
Patients susceptible to MH have a defective calcium
channel on the sarcoplasmic reticulum of the skeletal
muscle cells.
Symptoms arise from hypermetabolism of skeletal
muscles, probably as a result of uncontrolled release of
calcium from the sarcoplasmic reticulum and calcium entry
from the extracellular space or decrease in calcium uptake.
Resulting in sustained, uncoordinated muscles contraction
and metabolism increases, massive oxygen consumption
and production of lactic acid, heat and carbon dioxide.
4. PATHOPHYSIOLOGY OF
MALIGNANT HYPERTHERMIA
Rapid ATP consumption
Cellular acid content increases
Cell membranes breakdown
Muscle break down begins (rhabdomyolysis)
Cardiac changes - tachycardia and dysrythmia,
hypotention, decreased cardiac output, cardiac arrest.
Lab indicators
Creatine kinase – high levels indicate muscle
breakdown
Potassium (hyperkalemia) – leads to cardiac arrest
5. WHO IS SUSCEPTIBLE?
So who is susceptible?
MH is inherited with an autosomal dominant inheritance
pattern linked to as many as 80 genetic defects.
Carriers with susceptibility often are unaware they are
at risk.
The rate of occurrence is estimated to be as frequent
as 1 in 200 cases or as rare as 1 in 65,000.
Children and young adults are at greater risk.
As many as 5% do not survive an MH event.
A susceptible patient may have previous surgeries,
exposed to triggering agents, without a reaction but
have an MH crisis in subsequent exposure.
6. SO WHAT ARE WE DOING TODAY?
The goal of today is to address how an MH crisis
would be treated at this facility.
Prevention:
Preoperative questions & planning
Recognition
Recognize signs and symptoms
Treatment:
Response/duties cards
Introduction to the emergency cart.
Walk through a mock code.
Transfer:
Discuss transfer protocol.
7. PREVENTION:
PREOPERATIVE QUESTIONING
It is important to ask questions regarding the
patient’s anesthesia & health history as well as
family member’s history.
If there is any concern or red-flag regarding
susceptibility to MH, contact the anesthesia
provider.
Preparation for a possible MH patient is critical.
Prevention is the best treatment!
8. PREVENTION:
PREOPERATIVE QUESTIONING (CONTINUED)
History and Physical appointment should ask about any
anesthesia problems in the patient’s past or any family
members’ past. The conversation should include
questions to exploring the subject of MH.
Has you ever had a “bad” reaction to anesthesia?
Have you or a family member had a problem with
anesthesia?
Have you or a family member had a fever while under
anesthesia?
Has a family member died unexpectedly in the OR?
Have you or anyone in your family experienced a heat stroke
that resulted in hospitalization?
Have you ever noticed dark “cola-colored” urine after general
anesthesia or after a heat-related illness?
Do you or anyone in your family have a neuromuscular
disorder?
10. PREVENTION:
PREOPERATIVE PLAN
Malignant hyperthermia can be avoided by eliminating
triggering agents. Educate the patient that, if they are a
susceptible patient, that does not mean his/her case
would be cancelled.
Patients CAN have outpatient surgery even if they have
had previous MH event or a family history.
Talk to the anesthesia provider if you have a patient you
are concerned about.
Have a plan, have appropriate supplies, educate and
practice.
11. PATIENT WITH KNOWN OR SUSPECTED MH
HAVING ELECTIVE SURGERY
Patients can have had an uneventful anesthesia in
the past but still have an MH reaction in a later
surgery. Do not assume there will be no MH
reaction if the patient had an uneventful surgery
before.
Dantrium (dantrolene) capsules are available as a
prophylactic for patient with suspected MH, but not
widely used. Decision would be made by
anesthesia provider to use prophylactic treatment.
Avoidance of triggering agents is primary
prophylactic approach.
12. PATIENT WITH KNOWN OR
SUSPECTED MH HAVING OUTPATIEN
SURGERY (CONTINUED)
Pre-inform anesthesia provider.
Schedule as first case of the day.
No Triggering Agents to be used!!
Be prepared with dantrolene& MH cart.
Closely monitor early signs of MH.
Any patient suspected of MH should remain in
PACU for 4 hours for monitoring.
Testing is available at special centers. Susceptibility is
determined by the caffeine-halothane contracture test which
involves taking a biopsy of skeletal muscles. Information
regarding testing can be found at www.MHAUS.org.
13. EARLY RECOGNITION OF MH
Generally first diagnosed by anesthesia provider
Early diagnosis is critical for patient survival
MH symptoms can initiate in PACU
Signs and symptoms
Elevated end tidal CO2 or tachypnea
Increase oxygen consumption
Tachycardia & PVC’s
Cardiac arrhythmia
Unstable blood pressure
Sweating, mottled skin
Masseter spasm
Generalized muscle stiffness or rigidity
Metabolic and respiratory acidosis
14. LATE SIGNS & SYMPTOMS OF MH
Elevated temperature
Temperature can increase 1.8° F every 3 minutes
Metabolic and respiratory acidosis
Presence of creatine kinase
Hyperkalemia
Hypercalemia
Dark urine (myoglobinuria – myoglobin in urine)
Severe cardiac arrhythmia and cardiac arrest
Disseminated intravascular coagulation (DIC)
Left ventricular failure – pulmonary edema - death
15. PROMPT TREATMENT
Early Treatment – Anesthesia will run the crisis!
Dantrolene mixed and administered quickly .
Initiate transfer protocol.
Effective Treatment
ALL HANDS ON DECK!
Working as a prepared team.
Act Quickly…SAVE A LIFE
16. TREATMENT: EMERGENCY ABCD’S OF
MALIGNANT HYPERTHERMIA
A =
Agents – stop all triggering agents
Administer non-triggering anesthetics
Ask for help
Ask for MH Cart
B = Breathing – hyperventilation with 100%
oxygen
C = Cooling procedures if patient is > 102.2
D = Dantrolene – continuous rapid IV push
17. USE YOUR RESOURCES -
YOU’RE NOT ALONE!
Call for all nurses to report to the OR!
“Code MH” (or other designated code)
Call the 1-800 644-9737 to speak to MHAUS
Hotline. Anesthesia provider should speak with
them on a cell phone.
Pull MH Emergency Response Cards and assign 4
nurses their duties.
MHAUS wall posters available from MHAUS.
19. CIRCULATING NURSE
Call for help – assign nursing duties (dantrolene,
medication and cooling nurse).
Assign someone to call 911….critical step!
Assign someone to inform other anesthesiologist if
available. NO NEW CASES TO START IN THE
OTHER ORs – ALL HELP NEEDED FOR MH
CRISIS
Assign someone to notify the surgery center
manager and/or administrator of the situation.
20. CIRCULATING NURSE
Assist anesthesia as needed to:
Call MHAUS – number on treatment cards
Change circuit & soda absorbent (have with MH
supplies).
Start large bore IV – discontinue LR and hang N/S.
Draw labs/urine specimen.
You are still circulating so keep the surgery in mind.
Help the surgeon/scrub close or pack for transfer.
What you cannot do – DELEGATE!
21. DANTROLENE SODIUM
- THE drug for MH
Dantrolene acts as a skeletal muscle relaxant by acting
on calcium channels, suppressing the rise of calcium in
muscle cells that trigger the MH response.
Dantrolene is generic name. Dantrium and Revonto are
name brand.
Reconstitute with preservative-freesterile water.
Each facility should have 36 vials on hand, located close
to the OR, with code cart is logical location. Sharing
vials with other facilities is not recommended.
Average of 30 vials used per crisis.
IV Dantrolene treatment will continue during
transportation and up to 36 hours in ICU.
22. DANTROLENE NURSE
Obtain code cart if not already in the OR.
Start mixing dantrolene (skeletal muscle relaxant).
Each vial has 3g of mannitol included (renal vasodilator).
Mix with preservative-free sterile water
60ml sterile water per dantrolene vial
Create a fluid path with short IV tubing and stopcock for
rapid mixing.
Use spikes for rapid injection into vial
Shake until clear - 2 ½ - 4 minutes to mix. (New quick-
mixing versions make reconstitution much easier and
quicker).
23. DANTROLENE NURSE
Get all the help that you can to mix the dantrolene. A
minimum of 2-4 people needed.
Rapid IV push of dantrolene once diluted.
Initial dosing of dantrolene = 2.5 mg/kg (20mg/bottle)
Quick conversion dosage chart located on MH cards
Weight Initial Dose via rapid IV push
110lb = 50kg 125mg 6.25 vials
132lb = 60kg 150mg 7.5 vials
154lb = 70kg 175mg 8.75 vials
176lb = 80kg 200mg 10 vials
198lb = 90kg 225mg 11.25 vials
220lb = 100kg 250mg 12.5 vials
Send dantrolene vials with patient during transfer for
continued treatment.
24. MEDICATION NURSE
Therapy aimed at treating hyperkalemia, acidosis,
arrhythmia and increasing urinary output.
Medications to be prepared to give
Sodium Bicarbonate (treat metabolic acidosis)
Furosemide (increase urinary output)
Dextrose (treat hyperkalemia)
Calcium chloride (treat hyperkalemia)
Regular insulin (treat hyperkalemia)
Lidocaine (treat arrhythmias)
Amiodarone (treat arrythmias)
25. MEDICATION NURSE - DOCUMENTATION
Record keeping
Assign recording to another person if available
Specialized “Malignant Hyperthermia Critical
Intervention Record” is available from MHAUS
Complex form – be familiar with the form before you
need to use it
Focus documentation on:
Medications given
Time given
Dosage
Patient response
Nursing interventions
Cooling measures
26. COOLING NURSE
Discontinue warming blanket if in use.
Provide anesthesiologist with an esophageal
temperature probe (should be with MH supplies).
Cooling protocol starts at 102.2°.
Patient warms at a rapid rate so begin gathering
cooling supplies even if patient is not at treatable
temperature.
27. COOLING NURSE
Cooling techniques:
Cold IV and bottled sterile saline in refrigerators.
Cool the patient surface by putting ice packs to groin,
axillea and head
Be prepared to lavage stomach, bladder and rectum
with cold saline.
Provide cold sterile saline for lavage of open cavity.
Discontinue cooling measures when temperature
decreases to 100.4 °> to avoid hypothermia.
28. SO, WHAT’S MY JOB?
You do not know which job you will have during an
MH event so you must be familiar with all 4 nurse
assignment.
All 4 nurses’ responsibilities will be important and
stressful.
29. CODE & MH CART
Keep it stocked and organized.
Take time to go through the cart and be familiar with
the contents.
Keep ice available.
Cold saline in refrigerator.
30. WHAT’S SHOULD BE IN
EMERGENCY CART?
Medications Supplies
Dantrolene – 36 vials Anesthesia circuit and
Sterile preservative free water sodasorb
Sodium Bicarbonate 8.4% (50ml Temperature probe
x 5) 60 cc syringes
Furosemide
Mini-spikes
(40mg/amp x 4 amps)
Fluid transfer tubing
Dextrose 50%
(50ml vials x 2)
N/G tube & Toomey syringes
for irrigation
Calcium Chloride
Foley
10% (10ml vial x 2)
Zip baggies for ice packs
Regular Insulin
(100 units x 1 refrigerated) Large bore IV’s
Lidocaine preloaded syringes ICE & 3 Ls of cold IV and
(100mg) x 3 or Amiodorone bottles saline in refrigerator
31. A CLOSER LOOK at MEDICATIONS
Dantrolene – muscle relaxant
Sterile preservative free water – for dilution
Sodium Bicarbonate – treat metabolic acidosis
and hyperkalemia
Furosemide – maintain urine output
Insulin & Dextrose - treat hyperkalemia
Calcium Chloride – treat hyperkalemia
Lidocaine or Amiodorone - treat dysrhythmias
32. TRANSFER PROTOCOL
Outpatient surgery centers have the added obstacle
of having to transfer the patient to an inpatient
facility for complete treatment of an MH event.
Call 911 early to begin transfer process.
Direct personal communication – anesthesia to
physicians at the hospital – is strongly
recommended.
Have a “Transfer of a Patient” protocol in place and
make sure everyone knows where it is and how to
use it.
33. TRANSFER PROTOCOL
Patient should be moved when, according to
anesthesia, the patient is showing signs of stability.
Anesthesia provider will make decision of timing of
transfer.
Signs of stability are:
EtCO2 in declining
Heart rate is stable or decreasing with no ominous
dysrythmias
Dantrolene administration has begun
Temperature is normal or declining
If present, generalized muscular rigidity is resolving
34. TREATMENT AT A GLANCE
“Some hot dude better give iced fluids fast”
Stop triggering agent
Hyperventilate with 100% O2
Dantrolene
Bicarbonate
Glucose and Insulin
Ice and cooling measures – lavage, surface &
wound
Fluids – IV fluids in and Lasix for output
Fast – treat tachycardia/V-tach
35. TIME TO DO A MOCK CODE!
REMEMBER…..
Take this opportunity to practice without harming a
patient.
Be comfortable – you’re among friends.
You can’t make a mistake here.
36. REFERENCES
AORN Perioperative Nursing Video Library (2009). Video: Malignant
Hyperthermia; Keeping your cool [DVD video]. USA:Cine-Med.
Helmer, M. & Carlson, K. (2010). Malignant Hyperthermia: Perioperative
crisis [PowerPoint slides]. Retrieved September 27, 2010 from
http://www.nursingceportal.com/CECourses/Description/38
MHAUS (2010). Guide to malignant hyperthemia in an anesthesia setting.
Available at www.mhaus.org
MHAUS (2010). Transfer plans for suspected MH patients [poster]. Available
at www.mhaus.org
Reno, D. (senior editor.) (2008). Perioperative standards and recommended
practices (2008 Ed.). Denver: AORN